Injectable Drug Delivery is the transport of drugs into the body in liquid form which is the fast transport of the drug into the body. It is considered as the most common method to achieve the desired quick response. These injections are used in various applications like autoimmune diseases, hormonal imbalance, Wilson’s disease, hemophilia and other diseases. In the recent years, this market has showcasing development because of the expanded predominance of cancer and diabetes.
According to the report Global Injectable Drug Delivery Market, published by Market Data Forecast, the Global market is projected to reach USD 696.32 billion by 2022, at a CAGR of 11.5% from 2017 to 2022.
Global Injectable Drug Delivery Market: Drivers & Restraints
The Global Injectable Drug Delivery Market is driven by the factors like increased prevalence of chronic diseases, rising demand for biologics in the pharmaceutical industry, increased patient compliance and aged population, new product innovations and technological advances in the form of nanotechnologies. However, restraining factors affecting the global market are emergence of alternative drug delivery systems, possibility of injuries and infections, stringent rules and regulatory framework concerns.
Get accurate market forecast and analysis on the Global Injectable Drug Delivery Market.
Global Injectable Drug Delivery Market: Segmentation
By Device Type
- Self-injection Devices
- Conventional Devices
- Conventional Drug Delivery
- Novel Drug Delivery
By Therapeutic Use
- Autoimmune Disorders
- Hormonal Disorders
- Homecare Settings
- Research Institutes
- Clinical Laboratories
- North America
o United States
o South Korea
- Latin America
o Rest of Latin America
- Middle East & Africa
Global Injectable Drug Delivery Market: Overview
In 2017, conventional devices have the largest share in terms of revenue by formulation. In therapeutic use, autoimmune disorders command the highest share and oncology segment is growing at the fastest pace due to the rapid growth of chronic diseases like cancer.
In end-user, hospitals are the largest segment in the global market.
The Global Injectable Drug Delivery Market is dominated by North America in 2016 with the region accounting for 35% of the overall market share. North America was followed by Europe and Asia-Pacific.
Asia Pacific is predicted to grow at a rapid pace in the coming few years due to the rise in chronic diseases with the rise in population, high investment by private companies in this area and emerging economies like China and India.
Global Injectable Drug Delivery Market: Key Players
The major companies dominating the market, by their products and services include Bend Research, Alkermes Inc., BIND Biosciences, Inc., and Genentech Inc., MicroCHIPS, Inc. other companies include Endocyte, Pearl Therapeutics Inc., Presage Bioscience, Polymer Factory, QLT Inc., UCB Group.
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!